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I nitiation of malignant melanocytic proliferation throughactivationof themitogen-activatedproteinkinase (MAPK)pathwaymost commonly involves themutation ofmutu-
ally exclusive BRAF or NRAS.1 Constitutive activation of the
MAPK pathway drives subsequent expression of a variety of
oncogenes resulting in a transformedphenotype secondary to
cell growthpromotion.2BRAFmutational frequency inmela-
noma is commonly a substitution of valine by glutamic acid
at codon 600 (V600E),3 accounting for 74% to 90% of BRAF
mutations in thismalignantneoplasm.4TheBRAFV600Emu-
tation has also been detected in 73% to 82% of melanocytic
nevi, implicating this genemutation in the initiation ofmela-
nocytic neoplasia.1,2
The role of the BRAFmutation in the current genetic ba-
sis ofmelanomadevelopment andprogression is basedon the
Clarkmodel formelanomaprogression,5 corresponding to the
proposedmorphologic changes fromabenignnevus to a dys-
plastic nevus to amelanoma.6 Thus, an alternative divergent
molecularpathwaygeneticmodelhasbeenproposed forBRAF
or NRAS wild-type melanomas, developing possibly by acti-
vationof cell-cycle regulatory genes serving independent on-
cogenic function.2Wehereindescribe thephenotypic charac-
teristicsandhighlight themolecular complexityofamelanoma
in situ arising within a dysplastic nevus via dermoscopy-
targeted sampling and genotyping using a miniaturized bi-
opsy device.
Report of a Case
This study was approved by the Princess Alexandra Hospital
human research ethics committee. Thepatient providedwrit-
ten informed consent in accordance with the Declaration of
Helsinki.
Aman in his 50swith Fitzpatrick skin type II and a family
historyofmelanomapresentedwitha5 × 3-mmirregularlypig-
mentedmelanocytic lesion onhis left lower back detected on
routineskinexamination.Thepatientunderwent imagingwith
the FotoFinder system (FotoFinder Systems Inc) of all nevi
larger than 5 mm and also those between 2 and 5 mm on the
back as part of a study on nevus morphology.7 The total nevi
count was 42, with 36 nevi on the back and 6 nevi on the rest
IMPORTANCE The BRAF V600Emutation accounts for themajority of BRAFmutations found
in cutaneous melanoma and is also commonly found in nevi. We used dermoscopy-targeted
sampling and amicrobiopsy device coupled with DNA sequence analysis to highlight BRAF
V600E heterogeneity within a multicomponent melanocytic proliferation. This sampling
technique demonstrates the prospect of in vivo application in a clinical setting.
OBSERVATIONS Aman in his 50s with Fitzpatrick skin type II presented with an irregularly
pigmentedmelanocytic lesion on his back that met melanoma-specific dermoscopic criteria,
and diagnostic shave excision of the lesion was performed. Histopathologic analysis revealed
amelanoma in situ arising in a dysplastic nevus. Dermoscopy-targetedmicrobiopsy
specimens were taken across the lesion, and genotyping was carried out on extracted DNA
samples for BRAF and NRASmutations. Themelanoma in situ showed only BRAFwild-type
results, while the dysplastic nevus showed both BRAFwild-type and BRAF V600Emutations.
Sequencing in all DNA samples revealed NRASwild-type genotype.
CONCLUSIONS AND RELEVANCE Dermoscopy-targeted sampling and genotyping of a
melanoma in situ arising in a dysplastic nevus revealed a phenotype-genotype paradox that
confounds the exclusive significance of BRAF and NRASmutations in melanoma
pathogenesis. Further studies are required to investigate the importance of other candidate
genes linked tomelanomagenesis.
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of the body; 35 of 36 of the nevi on the back measured be-
tween2and5mm.Thepatient’s germlineMC1Rgenotypewas
wild-type.
Dermoscopy unveiled a pigmented macule with multi-
component pattern (Figure 1A, Figure 2A, and Figure 3A)—a
normal reticularpatternonthe left sideof the lesion, somecon-
fluent blue areas at the center of the lesion, and a well-
circumscribed areameasuring 1 × 1mmand characterized by
anatypical pigmentnetworkanda few irregular streakson the
right side of the lesion at the 4-o’clock corner. The lesionmet
the 3-point checklist criteria for a melanoma with the pres-
enceof 2 features in that it hadasymmetry andanatypical pig-
ment network. It also showedmelanoma-specific local crite-
ria (atypical pigment network and irregular streaks), and so a
diagnostic shave excision of the lesion was performed.
Theexcised lesionwasevaluatedby2 independentboard-
certified dermatopathologists (D.L. and H.P.S.). Histopatho-
logic findingsof the left sideof the lesionwere consistentwith
adysplastic nevus characterizedby elongatedpigmented rete
ridges, discrete nests ofmelanocytes, and few singlemelano-
cytesmostly along thedermoepidermal junction correspond-
ing with the typical pigment network seen on dermoscopy
(Figure 1). Similar morphologic findings were present at the
center of the lesion with evidence of amplemelanophages in
thepapillarydermis accounting for the subtleblueareasnoted
ondermoscopy (Figure2).Histopathologic analysisof the right
sideof the lesion revealed features suggestiveof anearlymela-
noma in situ characterized by an increased number of atypi-
Figure 1. Dermoscopy and Hematoxylin-Eosin–Stained Histopathology
Images Corresponding to the Left Side of the Subject Lesion
A
B
C
1 mm
200 µm
100 µm
A, Circled area of the dermoscopy image reveals a normal reticular pattern
without any dermoscopic criteria suggestive for melanoma; dermoscopy-
targetedmicrobiopsy samples were taken from this circled area; vertical line
corresponds to the site of the specimen shown in panel B. B, Photomicrograph
of the histologic specimen reveals a rather conventional dysplastic nevus; boxed
area corresponds to themagnified area shown in panel C. C, Higher
magnification of the boxed section displays elongated pigmented rete ridges,
discrete nests of melanocytes, and few single melanocytes, mostly along the
dermoepidermal junction; a microbiopsy defect can be seen in this frame
(arrowhead).
Figure 2. Dermoscopy and Hematoxylin-Eosin–Stained Histopathology
Images Corresponding to the Center of the Subject Lesion
A
B
C
200 µm
1 mm
100 µm
A, Circled area of the dermoscopy image reveals a slightly more pigmented
typical pigment network and subtle blue areas; dermoscopy-targeted
microbiopsy samples were taken from this circled area; vertical line corresponds
to the site of the specimen shown in panel B. B, Photomicrograph of the
histologic specimen reveals a dysplastic nevus without any remarkable
histopathologic findings; boxed area corresponds to themagnified area shown
in panel C. C, Higher magnification of the boxed section exhibits a slightly
increased number of melanophages in the papillary dermis, most probably
reflecting the subtle bluish pigmentation at the center of the lesion.
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cal melanocytes at all levels of the epidermis corresponding
to the well-circumscribed area at the 4-o’clock corner arising
in an otherwise conventional predominantly junctional dys-
plastic nevus (Figure 3).
We used a new miniaturized biopsy device to sample le-
sional tissue for molecular analysis.8 This sampling tech-
nique has been shown not to cause significant disruption to
the lesionarchitectureandthuswouldnotcompromise thehis-
topathologic assessment.9,10 First, a transparent plate with a
pinhole was coupled with a dermoscope to visualize the de-
sired area for sampling. The dermoscope was removed once
the areawas identified through the pinhole, leaving the plate
in contactwith the lesion and rendering the area for sampling
accessible to the biopsy device microneedle. The microbi-
opsy device applicator was then aligned with the pinhole al-
lowing for targeted samplingof the tissue. Threedermoscopy-
guided microbiopsy specimens were taken from each of the
described dermoscopic areas in the excised lesion using this
technique (Figure 4A).
Samples ofDNAwere extracted from themicrobiopsy tis-
sue specimens using the QIAamp DNAMicro Kit followed by
whole genomic amplification carried outwith REPLI-g Single
Cell Kit according tomanufacturer’s protocols (QIAGEN). The
quality and integrity of amplifiedDNAwasvalidatedusing the
Bioanalyzer DNA 12000 kit (Agilent Technologies Inc). Gene-
specific forward and reverse primers flanking BRAF exon 15
and NRAS exon 2 mutation hotspots were used for poly-
merase chain reaction.10,11 Sanger sequencing was then car-
ried out on the DNA amplified products for BRAF and NRAS
mutationdetection,withBRAFV600Emutationdetectioncon-
firmedusing aMALDI-TOFmass spectrometry assay (eFigure
in the Supplement).
Themicrobiopsy-extractedDNAsamples fromthe left side
and center of the lesion revealed BRAFV600E heterogeneity,
while no BRAF V600E mutation was found in any of the
samples taken fromthemelanoma in situ (Figure4B).Ofnote,
molecular sequencingof allmicrobiopsy specimensacross the
lesion revealed noNRASmutation at codon 61. Thus, somatic
genomicprofiling andmolecular landscapingof this lesion re-
vealed theparadoxical findingofamelanomainsituwithBRAF
wild-typeDNAarising in adysplasticnevusheterogeneous for
the BRAF V600Emutation.
Discussion
Wedescribe herein the use of aminiaturized biopsy device to
evaluate a melanoma in situ with a BRAF wild-type DNA se-
quencedevelopingwithin a heterogeneousBRAFV600Emu-
tant dysplastic nevus. A dermoscope was used as a targeting
tool to improvethesamplingofdistinctdermoscopicareas from
within this multicomponent lesion. We observed that all
samples from themelanoma in situ were concordantly BRAF
wild-type, whereas the BRAF V600E mutation was detected
in the other 2 dermoscopic areas within the same melano-
cytic lesion.
Mutation of the BRAF gene in melanoma arising within
nevi was recently studied using DNA extraction of 1 or mul-
tiple laser-capture-microdissected, formalin-fixed, paraffin-
embedded, 5-μm-thick histologic sections that were hema-
toxylin-eosin stainedand thensubjected toSanger sequencing
and immunohistochemical analysis.11 This study observed 5
cases (about11%)ofBRAFwild-typesuperficial spreadingmela-
noma adjacent to a BRAF V600E mutated nevus, which was
not statistically significant. Additionally, the investigators
foundmelanoma-associated nevi to be either strictly dermal
or compound type, leading Tschandl et al11 to conclude that
theirphenotypic andgenotypic findingsdidnotmirror the tra-
ditional model of stepwise tumor progression. In compari-
son,wewere able to demonstrate this phenomenon in a thin-
ner melanoma using dermoscopy-targeted sampling with a
microbiopsy device coupledwithDNA sequence analysis, ac-
centuating the potential role of this minimally invasive tech-
Figure 3. Dermoscopy and Hematoxylin-Eosin–Stained Histopathology
Images Corresponding to the Right Side of the Subject Lesion
A
B
C
200 µm
1 mm
100 µm
A, Circled area of the dermoscopy image displays a 1 × 1-mmwell-circumscribed
area with an atypical broadened pigment network and irregular streaks at the
4-o’clock corner; dermoscopy-targetedmicrobiopsy samples were taken from
this circled area; vertical line corresponds to the site of the specimen shown in
panel B. B, Photomicrograph of the histologic specimen reveals features
suggestive of an early evolving melanoma in situ arising within a dysplastic
nevus. C, Higher magnification of the boxed section shows architectural
disarray with predominantly single atypical melanocytes at all levels of the
epidermis.
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nique in providing insight into intralesional heterogeneity in
melanocytic lesions in vivo.12Moreover, thephenotypic char-
acteristics of our melanocytic lesion fits with the Clark clini-
copathologic model in that the melanoma developed within
a dysplastic nevus,6 though this is undermined by the para-
dox in our lesion’s genetic signature.
Although histopathologic criteria have traditionally been
the practical reference standard in melanoma diagnosis and
staging, recent discovery of tumors harboring different onco-
genicmutationshas implicated theexistenceofmolecular sub-
groupsofmelanoma.2Theevaluationofearly cutaneousmela-
nomas in particular would benefit from a shift toward an
integratedphenotype-genotypemelanomaclassification sys-
tem, insteadof usingmorphologic criteria alone, because this
enables future development of melanoma-specific biomark-
ers toaid inmelanomadetection independentofdisease stage.
Othercandidategenes linkedtomelanomagenesis suchascKIT,
GNAQ,GNA11,RAC1,TERT,PTEN,andNF113 remain tobestud-
ied in the lesion described herein.
Similarly,BRAF andNRAS genemutations have been used
asgeneticmarkers instudiesattemptingto integrategeneticand
morphologic features to improvemelanoma classification.14,15
However, thehighconcordance rate (80.4%)ofBRAFmutation
betweenmelanomaand its associatednevus counterpart dem-
onstrated by Tschandl et al11 as well as the occurrence ofBRAF
wild-type melanoma arising in a BRAF V600E mutated nevus
suggest that other molecular signatures are involved in mela-
nomadevelopment. Onemay argue that our findingsmight re-
sult from themicroneedle deviating from the exact desired lo-
cation despite an attempt to improve sampling accuracy using
a dermoscope, as well as the remote possibility that the mi-
croneedle did not sample melanocytes and so consequently
yielded the wild-type sequence. Nonetheless, conventional
methods such as laser-capture microdissection also present a
probability of not sampling BRAF-mutantmelanocytes.
Conclusions
Our observation supports other reports on the limitations of
currentmelanomabiomarkers in deconstructing themolecu-
lar events responsible for tumorigenesis. Further large-scale
studiesare required to investigate thesignificanceofothercan-
didategenes linkedtomelanomagenesis.Translationofamini-
mally invasive invivomicrobiopsydevice insampling formela-
noma-specific biomarkers may have a prospective role in the
nextphaseofmelanomadiagnosis, risk stratification, andper-
sonalized therapeutics.
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Figure 4. Three Sampled Sectors of the Subject Lesion and Their Corresponding BRAFV600EMutation Status
C C CA A A A A A A A A A A A A A A A AT T T T T TG G G G G G
Codon 600 Codon 600 Codon 600
Area I Area II Area III
I II III
A
B
A, Dermoscopy image specifying the
locations where microbiopsy samples
were taken from each dermoscopic
area (circles) of the subject lesion
with the aid of a dermoscope; area I
corresponds to Figure 1; area II, to
Figure 2; and area III, to Figure 3.
B, Representative chromatograms
corresponding to areas I, II, and III of
the lesion, as shown in panel A; BRAF
V600Emutation was detected in
areas I and II (highlighted as A/T in
the boxed areas); conversely, no
mutation was detected in area III.
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NOTABLENOTES
Frostbite and Chilblains in Upton Sinclair’s The Jungle
Tina M. Banzon, BA; Scott A. Norton, MD, MPH
InThe Jungle,1 authorUptonSinclair uses cold exposure injuries to illus-
trate exploitation of America’s laboring classes by ruthlessly venal in-
dustrialists during theearly 20thcentury. In thebook,working-class im-
migrants inChicago’smeatpacking industrysuffervaryingdegreesofcold
injuryasaconsequenceofhostileworkingconditions. Injuries rangefrom
milder forms, including frostnip (superficial, local paresthesias without
tissue destruction), chilblains (painful edematous erythematous le-
sionsdue toacuteor repetitiveexposure tonear-freezingcold), tomore
serious conditions, such as frostbite (tissue destruction).
There was no heat upon the killing beds; the men might exactly as well
haveworked out of doors all winter. For thatmatter, therewas very little
heat anywhere in the building, except in the cooking rooms and such
places—and it was the men who worked in these who ran the most risk
of all, because whenever they had to pass to another room they had to
go through ice-cold corridors, and sometimeswith nothing on above the
waist except a sleeveless undershirt. On the killing beds youwere apt to
be covered with blood, and it would freeze solid. (chapter 7)
Stanislovascame…screamingwithpain.Theyunwrappedhim,andaman
began vigorously rubbing his ears; and as they were frozen stiff, it took
only two or three rubs to break them short off. (chapter 7)
All that they knewhow to dowas to hold the frozen fingers near the fire,
and so little Stanislovas spent most of the day dancing about in horrible
agony. (chapter 12)
In his novel, Sinclair1 hoped toexpose rampanthealth violations andun-
sanitary work practices, and to convey the hopelessness and wide-
spread exploitation of America’s working class during thewaning years
of America’s GildedAge and the early 20th century. Public response ul-
timately pressured Congress to enact the Meat Inspection Act and the
Pure Food and Drug Act in 1906, which strengthened regulation of the
meatpacking industry and improved treatmentof its employees.2Great
advances inpublichealthhavebeenmadesincepublicationofTheJungle,
but according toHumanRightsWatch,meatpacking remains the “most
dangerous factory job in the United States.”3 In addition, the demogra-
phyofmeatpackingworkershas shifted frommainly southernandeast-
ern European immigrants during the early 20th century (eg, The Jun-
gle’sprotagonist, JurgisRudkis,whosefamily immigratedfromLithuania)
to today’s meatpacking workforce, where most laborers come from
Mexico andCentral andSouthAmerica. Although threats of severe cold
exposure injuries may evoke a distant era, the workforce of America’s
meat and poultry industry allegedly still endures unsafe working
conditions,3 suggesting further public advocacy to prevent hazardous
(although probably both legal and profitable) practices that perpetu-
ate unsafe work conditions.
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